Chemistry Reference
In-Depth Information
P., Chokshi, H.P., Malick, A.W., and Choi, D.S. (2011) Prediction of the thermal phase
diagram of amorphous solid dispersions by Flory-Huggins theory.
J. Pharm. Sci.
,
100(8):3196-3207.
82. Tian, Y.W., Booth, J., Meehan, E., Jones, D.S., Li, S., and Andrews, G.P. (2013) Construc-
tion of drug-polymer thermodynamic phase diagrams using Flory-Huggins interaction
theory: identifying the relevance of temperature and drug weight fraction to phase separation
within solid dispersions.
Mol. Pharm.
, 10(1):236
248.
83. Ohtake, S. and Shalaev, E. (2013) Effect of water on the chemical stability of amorphous
pharmaceuticals. I. Small molecules.
J. Pharm. Sci.
, 102(4):1139-1154.
84. (a) Hancock, B.C. and Zografi, G. (1994) The relationship between the glass transition
temperature and the water content of amorphous pharmaceutical solids.
Pharm. Res.
,
11(4):471-477. (b) Roos, Y.H. and Karel, M. (1991) Plasticizing effect of water on thermal
behavior and crystallization of amorphous food models.
J. Food Sci.
, 56(1):38-43.
(c) Shalaev, E.Y. and Zografi, G. (1996) How does residual water affect the solid-state
degradation of drugs in the amorphous state?
J. Pharm. Sci.
, 85(11):1137-1141.
85. Marsac, P.J., Konno, H., Rumondor, A.C.F., and Taylor, L.S. (2008) Recrystallization of
nifedipine and felodipine from amorphous molecular level solid dispersions containing poly
(vinylpyrrolidone) and sorbed water.
Pharm. Res.
, 25(3):647-656.
86. Ghebre-Sellassie, I. and Martin, C. (2003)
Pharmaceutical Extrusion Technology
, Marcel
Dekker.
87. Sollohub, K. and Cal, K. (2010) Spray drying technique. II. Current applications in
pharmaceutical technology.
J. Pharm. Sci.
, 99(2):587-597.
88. (a) DiNunzio, J.C., Brough, C., Miller, D.A., Williams, R.O., and McGinity, J.W. (2010)
Applications of KinetiSol
Dispersing for the production of plasticizer free amorphous solid
dispersions.
Eur. J. Pharm. Sci.
, 40(3):179-187. (b) DiNunzio, J.C., Hughey, J.R., Brough,
C., Miller, D.A., Williams, R.O., and McGinity, J.W. (2010) Production of advanced solid
dispersions for enhanced bioavailability of itraconazole using KinetiSol
Dispersing.
Drug
Dev. Ind. Pharm.
, 36(9):1064-1078.
89. Warren, D.B., Bergström, C.A.S., Benameur, H., Porter, C.J.H., and Pouton, C.W. (2013)
Evaluation of the structural determinants of polymeric precipitation inhibitors using solvent
shift methods and principal component analysis.
Mol. Pharm.
, 10(8):2823
-
2848.
90. Wyttenbach, N., Janas, C., Siam, M., Lauer, M.E., Jacob, L., Scheubel, E., and Page, S.
(2013) Miniaturized screening of polymers for amorphous drug stabilization (SPADS): rapid
assessment of solid dispersion systems.
Eur. J. Pharm. Biopharm.
, 84(3):583-598.
91. Serajuddin, A.T.M., Thakur, A.B., Ghoshal, R.N., Fakes, M.G., Ranadive, S.A., Morris,
K.R., and Varia, S.A. (1999) Selection of solid dosage form composition through drug-
excipient compatibility testing.
J. Pharm. Sci.
, 88(7):696-704.
92. Hong, J.Y., Shah, J.C., and McGonagle, M.D. (2011) Effect of cyclodextrin derivation and
amorphous state of complex on accelerated degradation of ziprasidone.
J. Pharm. Sci.
,
100(7):2703-2716.
93. Bindra, D.S., Williams, T.D., and Stella, V.J. (1994) Degradation of
O
-6-benzylguanine in
aqueous polyethylene glycol 400 (PEG 400) solutions: concerns with formaldehyde in PEG
400.
Pharm. Res.
, 11(7):1060-1064.
94. (a) Bergh, M., Magnusson, K., Nilsson, J.L.G., and Karlberg, A.T. (1997) Contact allergenic
activity of Tween
80 before and after air exposure.
Contact Dermatitis
, 37(1):9-18.
(b) Bergh, M., Magnusson, K., Nilsson, J.L.G., and Karlberg, A.T. (1998) Formation of
-
